Infectious Disease
Show
- Medications
- Antibiotic tolerance study paves way for new treatments
- Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.
- 107 0
- Infection Protection
- NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
- The findings were published on Feb. 24 in JAMA Internal Medicine, and the results may explain why reinfection appears to be relatively rare.
- 1028 0
- Drug Trends
- Mouse study shows bacteriophage therapy could fight drug-resistant Klebsiella pneumoniae
- Phage therapy has been pursued for about a century, though conclusive research studies are rare and clinical results — have provided mixed results
- 355 0
- Immune System
- House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19
- U.S. Representative Glenn Grothman (R-WI) believes the agencies should further communications and investigations on the risks of vitamin D deficiency.
- 5663 0
-
- Medications
- Antibiotic tolerance study paves way for new treatments
- Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.
- 107 0
-
- Infection Protection
- NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
- The findings were published on Feb. 24 in JAMA Internal Medicine, and the results may explain why reinfection appears to be relatively rare.
- 1028 0
-
- Drug Trends
- Mouse study shows bacteriophage therapy could fight drug-resistant Klebsiella pneumoniae
- Phage therapy has been pursued for about a century, though conclusive research studies are rare and clinical results — have provided mixed results
- 355 0
-
- Immune System
- House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19
- U.S. Representative Glenn Grothman (R-WI) believes the agencies should further communications and investigations on the risks of vitamin D deficiency.
- 5663 0
Load More
